Table 3.
Age | Sex | Indication | Survival (years) | Mode of failure | Management |
---|---|---|---|---|---|
74 | M | OA | 0.25 | Infection | Two-stage revision |
82 | M | OA | 0.33 | Infection | DAIR and long-term suppression |
57 | M | OA | 0.5 | Infection | Two-stage revision |
62 | M | OA | 1.67 | Infection | Two-stage revision |
71 | F | #NU | 3.75 | Infection | DAIR and long-term suppression |
61 | F | OA | 4.3 | Aseptic loosening tibia | Revision |
55 | F | RA | 5.25 | Aseptic loosening tibia | Revision |
52 | F | RA | 5.8 | Instability | Revision |
74 | F | OA | 8.6 | Infection | Two-stage revision |
45 | F | OA | 9.6 | Instability | Revised |
M male, F female, OA osteoarthritis, RA rheumatoid arthritis, # fracture, NU non-union, DAIR debridement and implant retention